Technology
Health
Pharmaceutical
Theravance Biopharma
$18.169876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$18.16
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.06 (0.33%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell TBPH and other stocks, options, ETFs, and crypto commission-free!
About TBPH
Theravance Biopharma, Inc. operates as a biopharmaceutical company. It focuses on the discovery, research, development, and commercialization of small molecule medicines. Read More Its products include telavancin under the VIBATIV brand, revefenacin under the TD 4208 brand, and neprilysin. The company was founded in July 2013 and is headquartered in George Town, Cayman Islands.
Employees
363
Headquarters
George Town, George Town
Founded
2013
Market Cap
1.02B
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
209.65K
High Today
$18.41
Low Today
$18.00
Open Price
$18.19
Volume
185.57K
52 Week High
$35.48
52 Week Low
$15.18
Collections
Technology
Health
Pharmaceutical
Biopharmaceutical
2014 IPO
North America (Non-US/Canada)
North America
Price Paid on Robinhood
34% Lower
Right Now
52 Week Low
$21.04
Average Price Paid
$27.60
52 Week High
$35.48
Analyst Ratings
71%
of 7 ratings
Buy
71%
Hold
0%
Sell
29%
TBPH Earnings
-$1.64
-$1.35
-$1.05
-$0.76
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Jul 31, After Hours